Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:19 p.m.

    📋 United Therapeutics Corporation (UTHR) - Clinical Trial Update

    Filing Date: 2022-08-03

    Accepted: 2022-08-03 06:06:16

    Event Type: Clinical Trial Update

    Event Details:

    United Therapeutics Corporation (UTHR) Announces Clinical Trial Update United Therapeutics Corporation (UTHR) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: usefulness, mortality
    • Diseases/Conditions: pulmonary arterial hypertension, idiopathic pulmonary fibrosis
    • Collaboration: ADVANCE OUTCOMES

    🔬 Clinical Development Pipeline (United Therapeutics Corporation):

    Product Type Development Stage Therapeutic Area Source
    Ralinepag DRUG Phase PHASE3 PAH ClinicalTrials.gov
    Treprostinil Ultrasonic Nebulizer DEVICE Phase PHASE3 Progressive Pulmonary Fibrosis ClinicalTrials.gov
    Inhaled Treprostinil DRUG Phase PHASE3 Progressive Pulmonary Fibrosis ClinicalTrials.gov
    Placebo DRUG Phase PHASE3 Progressive Pulmonary Fibrosis ClinicalTrials.gov
    UT-231B DRUG Phase PHASE2 Hepatitis C ClinicalTrials.gov
    treprostinil sodium DRUG Phase PHASE4 Hypertension, Pulmonary ClinicalTrials.gov
    Treprostinil diethanolamine DRUG Phase PHASE1 Pulmonary Arterial Hypertension ClinicalTrials.gov
    oritavancin DRUG Phase PHASE2 Staphylococcal Skin Infections ClinicalTrials.gov
    Standardized meals OTHER Phase PHASE1 Hypertension, Pulmonary ClinicalTrials.gov
    Esomeprazole DRUG Phase PHASE1 Hypertension, Pulmonary ClinicalTrials.gov
    UT-15C SR (treprostinil diethanolamine) DRUG Phase PHASE1 Pulmonary Arterial Hypertension ClinicalTrials.gov
    Remodulin (treprostinil sodium) Injection DRUG Phase PHASE2 Peripheral Vascular Disease ClinicalTrials.gov
    UT-15C SR DRUG Phase PHASE3 Pulmonary Hypertension ClinicalTrials.gov
    UT-15C DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Remodulin® (treprostinil sodium) Injection DRUG Phase PHASE3 Critical Limb Ischemia ClinicalTrials.gov
    Tadalafil DRUG Phase PHASE4 Pulmonary Arterial Hypertension ClinicalTrials.gov
    13-cis-Retinoic Acid BIOLOGICAL Phase PHASE2 Primary Refractory Neuroblastoma ClinicalTrials.gov
    Subcutaneous Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) BIOLOGICAL Phase PHASE2 Primary Refractory Neuroblastoma ClinicalTrials.gov
    MAb-3F8 BIOLOGICAL Phase PHASE2 Primary Refractory Neuroblastoma ClinicalTrials.gov
    UT-15C 5 mg DRUG Phase PHASE3 Pulmonary Hypertension ClinicalTrials.gov
    UT-15C 0.25 mg DRUG Phase PHASE3 Pulmonary Hypertension ClinicalTrials.gov
    UT-15C 1 mg DRUG Phase PHASE3 Pulmonary Hypertension ClinicalTrials.gov
    Dinutuximab DRUG Preclinical Neuroblastoma ClinicalTrials.gov
    Treprostinil Inhalation Solution DRUG Phase PHASE2 Respiratory Distress Syndrome, Adult ClinicalTrials.gov
    Treprostinil DRUG Phase PHASE2 Pulmonary Arterial Hypertension ClinicalTrials.gov
    Treprostinil Diolamine DRUG Phase PHASE3 Pulmonary Arterial Hypertension ClinicalTrials.gov
    APD811 DRUG Phase PHASE2 Pulmonary Arterial Hypertension ClinicalTrials.gov
    PET/MRI OTHER Preclinical Pulmonary Arterial Hypertension ClinicalTrials.gov
    autologous adipose derived stem cells BIOLOGICAL Phase PHASE1 Rheumatoid Arthritis ClinicalTrials.gov
    Celltex- AdMSCs BIOLOGICAL Phase PHASE2 Osteoarthritis, Knee ClinicalTrials.gov
    autologous adipose-derived stem cells BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    Adipose-Derived Mesenchymal Stem Cells DRUG Preclinical Alzheimer Disease ClinicalTrials.gov
    Allogeneic adipose-derived stem cells BIOLOGICAL Phase PHASE2 Corona Virus Infection ClinicalTrials.gov
    Model 10642 Implantable Intravascular Catheter DEVICE Approved Pulmonary Arterial Hypertension ClinicalTrials.gov
    Treprostinil Inhalation Powder DRUG Phase PHASE1 Pulmonary Arterial Hypertension ClinicalTrials.gov
    CMP-CPS-001 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    T-1101 (Tosylate) DRUG Phase PHASE1 Advanced Refractory Solid Tumors ClinicalTrials.gov
    Right heart catheterization (RHC) PROCEDURE Preclinical Interstitial Lung Disease ClinicalTrials.gov
    Oral Treprostinil DRUG Phase PHASE4 Pulmonary Arterial Hypertension ClinicalTrials.gov
    Parenteral Treprostinil DRUG Phase PHASE4 Pulmonary Arterial Hypertension ClinicalTrials.gov
    Chidamide DRUG Phase PHASE2 Relapsed or Refractory Peripheral T-cell Lymphoma ClinicalTrials.gov
    T-1201 Injection 100 mg Kit DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Regorafenib DRUG Phase PHASE1 Hepatocellular Carcinoma (HCC) ClinicalTrials.gov
    Prospective study assessments OTHER Preclinical Pulmonary Hypertension Due to Lung Diseases and Hypoxia ClinicalTrials.gov
    GM-CSF DRUG Phase PHASE2 Neuroblastoma ClinicalTrials.gov
    Irinotecan DRUG Phase PHASE2 Neuroblastoma ClinicalTrials.gov
    Temozolomide DRUG Phase PHASE2 Neuroblastoma ClinicalTrials.gov
    Universal Donor (UD) TGFβi NK Cells DRUG Phase PHASE2 Neuroblastoma ClinicalTrials.gov
    T-1301 Capsules DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    ABM-168 DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Standard of Care BEHAVIORAL Approved Pulmonary Arterial Hypertension PAH ClinicalTrials.gov
    Exercise BEHAVIORAL Approved Pulmonary Arterial Hypertension PAH ClinicalTrials.gov
    Dinutuximab with Chemotherapy DRUG Phase PHASE1 Neuroblastoma ClinicalTrials.gov
    Inhaled Treprostinil (Tyvaso Nebulizer) DRUG Phase PHASE1 COPD (Chronic Obstructive Pulmonary Disease) ClinicalTrials.gov
    ECG-based AI Device - Results Not Returned to Investigator DEVICE Approved Pulmonary Hypertension ClinicalTrials.gov
    Echocardiogram and Right Heart Catheterization PROCEDURE Approved Pulmonary Hypertension ClinicalTrials.gov
    ECG-based AI Device - Results Returned to Investigator DEVICE Approved Pulmonary Hypertension ClinicalTrials.gov
    Potassium Iodide DRUG Phase PHASE1 Neuroblastoma ClinicalTrials.gov
    Sargramostim DRUG Phase PHASE1 Neuroblastoma ClinicalTrials.gov
    Vorinostat DRUG Phase PHASE1 Neuroblastoma ClinicalTrials.gov
    131I-MIBG RADIATION Phase PHASE1 Neuroblastoma ClinicalTrials.gov
    10 GE Xenokidney BIOLOGICAL Phase PHASE1 ESRD (End-Stage Renal Disease) ClinicalTrials.gov
    Myoelectric Implantable Recording Array (MIRA) DEVICE Approved Amputation ClinicalTrials.gov
    Lenalidomide DRUG Phase PHASE1 Neuroblastoma ClinicalTrials.gov
    NK Cells BIOLOGICAL Phase PHASE1 Neuroblastoma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: United Therapeutics Corporation
    • CIK: 0001082554
    • Ticker Symbol: UTHR
    • Period End Date: 2022-08-03
    • Document Type: 8-K

Search

News categories